Based only on the American Society of Hematology, what rows, columns, and data points should be included to complete the requested table?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 16, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

American Society of Hematology Diagnostic Criteria Tables

I cannot complete this request as specified because the provided evidence does not contain American Society of Hematology (ASH) guidelines for the diagnostic criteria you appear to be asking about.

What the Evidence Actually Contains

The evidence provided includes:

  • 1 - WHO 2008 classification criteria for myeloid neoplasms (polycythemia vera, essential thrombocythemia, primary myelofibrosis) - this is a WHO guideline, not ASH

  • 2 through 3 - Various guidelines and research on unrelated topics including:

    • Negative pressure wound therapy
    • CMML management (Italian societies, not ASH)
    • Non-small cell lung cancer
    • VTE management
    • Fever and neutropenia
    • Bronchoalveolar lavage
    • Workforce studies
    • Other ASH guidelines on VTE, pain management, and trial diversity

Critical Gap

None of the provided evidence contains ASH-specific diagnostic criteria tables for myeloproliferative neoplasms or other hematologic malignancies. The only diagnostic criteria tables present are from:

  • WHO classification 1
  • IWG consensus criteria for CMML and myelofibrosis 4 (Italian/European societies)
  • Various unrelated clinical contexts

What Would Be Needed

To complete your requested table based on ASH guidelines, I would need:

  • ASH-published diagnostic criteria for specific hematologic diseases
  • ASH consensus statements on disease classification
  • ASH-endorsed diagnostic algorithms

Please clarify which specific disease entity and which ASH guideline document you are referencing, or provide the actual ASH guideline evidence.

Related Questions

In a patient with a history of two thrombo‑embolic events and a possible hereditary protein C deficiency who is currently on lifelong apixaban (Eliquis) 5 mg twice daily, and whose labs show low protein C, elevated factor VIII, hyperhomocysteinemia, and borderline anticardiolipin IgG, should the anticoagulation regimen be adjusted?
What is the recommended testing and treatment for a patient with activated protein C resistance who has had a venous thromboembolism?
How should blood clots in a tracheostomy tube be managed one month after the operation?
How do I write a SOAP note for a patient with acute right calf pain and swelling suspected of deep vein thrombosis, who has recent long‑distance travel, a prior DVT, hypertension, and is on oral estrogen therapy?
What is the appropriate next step in management for a 56‑year‑old man with acute myeloid leukemia who has completed induction therapy and is in hematologic and marrow remission?
Can quetiapine (Seroquel) be used to treat anger, and what are the recommended dosing and monitoring guidelines?
Should a 79-year-old patient with a newly diagnosed lower-extremity deep vein thrombosis, started on apixaban (Eliquis) 5 mg twice daily, be referred to hematology?
Is a 2 mg dose of midazolam adequate to control a seizure, and what subsequent steps should be taken?
Can sertraline be taken twice daily?
What is the clinical significance of a plasma ADAMTS13 activity result less than 5%?
Can the combination of carfilzomib (Kyprolis), trastuzumab (Herceptin), and paclitaxel (Taxol) cause acneiform rash or pimples?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.